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Abstract 
Mucosal associated invariant T (MAIT) lymphocytes are characterized by two 
evolutionarily conserved features: an invariant TCRα chain and restriction by the MHC-
related protein, MR1. Here we show that MAIT cells are activated by cells infected with 
different strains of bacteria and yeasts, but not viruses, both in human and mouse. This 
activation requires cognate interaction between the invariant T cell receptor (TCR) and MR1, 
which can present a bacteria-derived ligand. In humans, we observe a striking diminution of 
MAIT cell blood-numbers in patients with bacterial infections such as tuberculosis. In mouse, 
MAIT cells protect against infections by Mycobacterium and Escherichia coli. Thus, MAIT 
cells are evolutionarily conserved innate-like lymphocytes that sense and help fight off 
microbial infections.  
 ‘Innate-like lymphocytes’ display features of both the innate and adaptive immune 
systems. In particular, B1 B cells1, 2, certain types of γδ T cells3 and Natural Killer T (NKT) 
cells4 express antigen receptors with limited diversity. These invariant lymphocyte subsets 
follow specific ontogenic pathways, home to particular tissues and have elevated clonal sizes 
compared to conventional lymphocytes5. These innate cells display immediate effector 
functions after stimulation, such as antibody production or cytokine secretion2, 5. 
Mucosal associated invariant T (MAIT) cells are another lymphocyte subset that 
expresses an evolutionarily conserved invariant TCRα chain, composed of the iVα7.2 
segment in humans and iVα19 in mice associated with the Jα33 segment.  They are selected 
on the highly phylogenetically conserved major histocompatability complex (MHC) class I 
related molecule, MR1 (90% homologous α1 and α2 domains between mouse and human, vs. 
60-70% for other MHC class I)6, 7. MAIT cells are abundant in human blood (1-8% of T cells 
vs. 0.01-1% for NKT cells), the intestinal mucosa and mesenteric lymph nodes (MLN)8. 
Human MAIT cells display a memory phenotype early in life, but are small in numbers and 
naïve in cord blood, suggesting MAIT cells expand after birth and acquire their memory 
phenotype in the presence of commensal flora8. Supporting this hypothesis, MAIT cells are 
not detectable in germ-free mice7. However, their number is increased in transporter 
associated with antigen processing and invariant chain double-deficient mice (Tap-/-Ii-/-), in 
which conventional T cell selection is impaired7, 9. Despite the availability of transgenic 
animals expressing MAIT cell-specific Vα19 and Vβ6 chains8, 10, 11, little is known about the 
function of these cells. However, their location in the gut and their remarkably conserved 
features in mice and humans, suggest an important role in response to microbes. 
  
3 
Here we show that MAIT cells respond to antigen presenting cells (APC) cocultured 
with bacteria in an MR1-dependent manner both in humans and mice. This activation is 
induced by a wide variety of bacteria and yeasts, but not by viruses. APCs acquire their 
stimulatory capacity very quickly after infection and a cognate interaction between the iTCR 
and MR1 is required. Moreover, this interaction has antibacterial potential in vivo, as MR1-
deficient animals are more susceptible to Mycobacterium abscessus and Escherichia coli 
infection. Finally, in humans, the number of MAIT cells is reduced in peripheral blood from 
patients with infectious diseases such as tuberculosis, while they are detected at the site of 
infection. We conclude that MAIT cells are evolutionarily conserved innate-like T cells with 
anti-microbial properties. 
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Results 
MR1- and bacteria-dependent activation of human MAIT cells 
The expansion and acquisition of a memory phenotype by human MAIT cells shortly 
after birth8 suggest that these cells could respond to bacteria. We isolated monocytes from 
peripheral blood mononuclear cells (PBMCs) and cocultured them with E. coli. Autologous 
sorted-Vα7.2 cells were seeded on these APCs at a 1:1 ratio and cultured overnight. Most 
MAIT cells, which are Vα7.2+CD161+ and either CD8βint or CD4-CD8β- double negative cells 
(DN)8, were activated as indicated by CD69 up-regulation (Fig. 1a). This activation was 
specific, as neither Vα7.2+CD161- conventional T cells from the same culture 
(Supplementary Fig. 1a), nor Vα7.2- CD4 and CD8 T cells cultured in parallel were 
activated (Supplementary Fig. 1b). MAIT cell activation was modulated by the 
bacteria:monocytes ratio, the multiplicity of infection (MOI) (Fig. 1b), and was completely 
abrogated by an anti-MR1 antibody (Fig. 1c). In contrast to mainstream memory T cells, 
MAIT cells secreted interferon (IFN)-γ (Fig. 1d) after stimulation with E. coli-infected 
monocytes, but not large amounts of interleukin (IL)-2, -4, -5, -13 or -17 (data not shown). 
Blockade of both CD69 upregulation (Fig. 1c) and IFNγ secretion (Fig. 1e) by the anti-MR1 
antibody indicates that cognate interaction between the TCR and the MHC-Ib molecules is 
required for MAIT activation. 
 
Decreased MAIT cell blood numbers in bacteria infected patients 
The bacterial reactivity of MAIT cells suggests their involvement in anti-bacterial 
defenses. We observed a significant decrease in MAIT cell proportions and absolute numbers 
in the blood of patients with pulmonary bacterial pathologies, including tuberculosis, as 
compared to healthy donors or patients with cancers (Fig. 2a and Supplementary Fig. 2a). 
The frequency of γδ T cells was unchanged while their absolute numbers were slightly 
decreased compared to healthy controls due to the lymphopenia found in some of these 
patients (Fig. 2b and Supplementary Fig. 2b). Taken together, these results indicate that the 
reduced MAIT cell frequency represents a true decrease in numbers and not a dilution by 
infection-reactive mainstream T cells. One possibility was that upon infection MAIT cells 
infiltrate tissues, decreasing their number in blood. To test this hypothesis, we visualized 
MAIT cells by tissue-immunofluorescence using anti-CD3, anti-Vα7.2 and anti-IL-18Rα, the 
latter of which correlates with CD161 expression (Fig. 2c). We observed MAIT cells in the 
lung lesions from two patients with Mycobacterium tuberculosis infection (Fig 2d). Similarly, 
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we obtained ascites fluid from patients with suspected ovarian malignancy. One patient 
analyzed had a higher MAIT cell number compared to blood and the other ascites (32% vs 
0.1-18.6%) (Fig. 2e). Strikingly, this patient was subsequently diagnosed with disseminated 
tuberculosis. These results indicate that human MAIT cells seem to migrate into infected 
tissues, suggesting that MAIT cells might have anti-microbial functions. 
 
Infected APCs rapidly stimulate mouse MAIT cells 
 
To investigate mouse MAIT cell activation by infected APCs, we cultured bone 
marrow-derived dendritic cells (BMDCs) from MR1-sufficient (Mr1+) or -deficient (Mr1-/-) 
animals and cocultured them with E. coli. As a source of MAIT cells, we used iVα19 and 
iVα19-Vβ6 transgenic (Tg) Cα- mice, which have elevated frequencies of these cells8. T cells 
from iVα19-Vβ6 (Fig. 3a) and iVα19 (Fig. 3b) Tg mice strongly up-regulated CD69 
expression when co-cultured with infected Mr1+, but not Mr1-/- BMDCs. Similarly to human 
MAIT cells, only CD8 and DN T cells were activated (Fig. 3a). We also observed MR1-
dependent CD25 up-regulation (Fig. 3c) and low amounts of IL-2 secretion by both iVα19 
single and iVα19-Vβ6 double Tg MAIT cells (Fig. 3d), consistent with their low proliferation 
capacities (Fig. 3e). Peritoneal macrophages cocultured with E. coli were also able to induce 
MAIT cell activation (data not shown), indicating that mouse MAIT cells respond to various 
types of infected-APCs in an MR1-dependent manner. 
To examine the role of soluble factors in MAIT cell activation, we fixed Mr1+ or Mr1-/- 
BMDCs with glutaraldehyde at different time points after infection, before adding iVα19-
Vβ6 Tg T cells. Three hours after infection, Mr1+ BMDCs were already able to stimulate 
MAIT cells (Fig. 4a), indicating that BMDC very rapidly acquire the MAIT cell stimulatory 
capacity. This also demonstrates that soluble factors such as cytokines are not necessary for 
MAIT cell activation. 
To further examine the cellular events required for MAIT cell activation, we treated 
BMDCs with several drugs modifying antigen processing before infection. Treatment of the 
BMDCs with dynasore, cytochalasin D and chloroquine (inhibitors of endocytosis and/or 
phagocytosis and endosomal acidification, respectively) strongly inhibited MAIT cell 
activation (Fig. 4b), indicating that bacteria or bacterially-derived compounds need to be 
internalized and processed. The proteasome inhibitor, lactacystin, did not show any effect 
(Fig. 4b) although it prevented ovalbumin-reactive OT-I TCR-Tg cell activation (data not 
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shown). Additionally, infected BMDC derived from Tap-/-Ii-/- animals activated MAIT cells 
equally well compared to wild-type Tap+/+Ii+/+ cells (Fig. 4c). Taken together, these results 
indicate that MAIT cell activation by BMDCs is independent of conventional MHC class I 
and class II antigen presentation pathways. 
 
Conserved interactions between invariant-TCR and MR1  
To study the evolutionary conservation of the TCR-MR1 interactions, we tested if 
human MAIT cells are activated by infected mouse APCs and vice versa. Sorted human 
MAIT cells were activated by E. coli infected APCs from Mr1+ but not Mr1-/- mice (Fig. 4d). 
Similarly, mouse hybridomas (6C2 and 8D12) expressing the iVα19-Vβ8 chains were 
stimulated by infected human monocytes as indicated by IL-2 secretion, which was 
completely abrogated by the addition of anti-MR1 (Fig. 4e). These results indicate that mouse 
and human MAIT cell TCRs interact similarly with MR1 on infected APCs. 
Looking at the TCR repertoire involved in MR1 reactivity, we observed that in iVα19 
single Tg mice, most CD8+ and DN T cells expressing the Vβ6 or Vβ8 segments (known to be 
preferentially found in MAIT cells8) responded to Mr1+, but not to Mr1-/- infected BMDCs 
(Fig. 3b). In contrast, 80% of the CD8+ and DN T cells expressing neither of these Vβ 
segments did not respond (Fig. 3b), excluding the possibility of an as yet unknown iVα19-
binding super-antigen. Additionally, MAIT cells did not require selection by MR1, but only 
expression of permissive Vβ segments in association with the iVα19 ΤCRα chain. Indeed, T 
cells from iVα19-Vβ6 double or iVα19 single Tg MR1-deficient mice were activated by E. 
coli infected BMDCs (Supplementary Fig. 3a & 3b). Finally, 10% of DN T cells from Tap-/-
Ii-/- Vβ6 single Tg mice were activated by infected BMDC in an MR1-dependent manner 
(Supplementary Fig. 3c) in line with our previous iVα19 quantification by RT-QPCR8. Thus, 
bacteria-infected APCs activate all mouse MAIT cells through MR1, regardless of the fine 
specificity imparted by the TCRβ chain indicating that expression of the iVα19 TCRα chain 
together with a permissive Vβ chain is sufficient to recognize MR1 on infected APCs. 
 
MAIT cells sense a wide variety of microbes 
These results suggest an extreme conservation of the bacterial component(s) involved in 
MAIT cell activation. To begin this characterization, we used heat-killed or paraformaldehyde 
(PFA)-fixed bacteria. Live bacteria were more efficient than dead microbes at inducing a 
MAIT cell response (Fig. 5a), but PFA-treated bacteria were able to trigger better activation 
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than heat-killed organisms (Fig. 5a), indicating that the compound responsible for MAIT 
activation is partially heat-labile but preserved by fixation. 
We then tested if one specific class of bacteria induces MAIT cell activation. Gram-
negative bacilli Pseudomonas aeroginosa and Klebsiella pneumoniae, Gram-positive 
Lactobacillus acidophilus and Gram-positive cocci Staphylococcus aureus and 
Staphylococcus epidermidis, all induced a strong response by both iVα19-Vβ6 and iVα19 Tg  
MAIT cells (Fig. 5b and data not shown, respectively). Surprisingly, Enterococcus faecalis 
and Streptococcus Group A, two bacteria closely related to Staphylococci, did not induce 
MAIT cell activation, even though all bacteria induced effective BMDC activation (data not 
shown). We obtained similar activation patterns for human MAIT cells by monocytes for the 
same panel of bacteria (data not shown). As Streptococci and Staphylococci share many 
microbial-associated molecular patterns (MAMPs)12, 13, these results suggest that some 
bacteria provide the necessary trigger for MAIT cell response while others do not. 
Alternatively, E. faecalis and Streptococci could actively inhibit the presentation of MR1 and 
its ligand. However, this hypothesis is refuted by the fact that PFA-fixed E. faecalis still do 
not induce MAIT cell activation (Fig. 5c) and infections with a mixed suspension of PFA-
killed E. coli and E. faecalis in a 1 to 10 ratio still do (Fig. 5c). These data strongly suggest 
that E. faecalis lacks the necessary compound for MR1-dependent MAIT activation. 
To address the specificity of MAIT cell responses to bacteria, as compared to other 
microbes, we tested viruses and yeasts in our in vitro model. Saccharomyces cerevisiae, 
Candida glabrata and Candida albicans infected BMDCs were able to induce a strong MAIT 
response in an MR1-dependent manner (Fig. 5d). On the other hand, several unrelated viruses 
(including Encephalomyocarditis, Sendai, Newcastle disease, Herpes simplex and 
Parainfluenza3 viruses), despite an ability to activate BMDC, failed to activate MAIT cells 
(Supplementary Fig. 4). These results suggest that MAIT cells respond preferentially to 
bacteria and yeasts.  
 
MAIT cells respond to a conserved exogenous antigen 
All these microbes can stimulate APCsby innate receptors such as Toll-like receptors 
(TLR) and Nod-like receptors (NLR) through recognition of common MAMPs. We tested if 
one of the TLR ligands could recapitulate bacteria-driven MAIT cell activation. Despite 
efficient activation of the BMDCs by Pam3Cys, polyIC, lipolysaccharide (LPS) or CpG, 
(ligands of TLR2, 3, 4 and 9, respectively14) (Supplementary Fig. 5a), no MR1-dependent 
activation was detected on iVα19-Vβ6 Tg MAIT cells (Supplementary Fig. 5b). We obtained 
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similar results using human monocytes and autologous MAIT cells (data not shown). We then 
used Myd88-/-, Trif-/- or Myd88-/--Trif-/- BMDCs, which are impaired in their response to many 
TLR ligands and IL-1β15, 16, 17, to study the response towards whole bacteria. iVα19-Vβ6 Tg 
MAIT cells were still receptive to stimulation by infected BMDCs from all knockout 
genotypes, although less efficiently compared to wild-type cells for MyD88-deficient BMDCs 
(Supplementary Fig. 6a). This reduction could be explained by impaired cellular activation 
of the BMDCs as indicated by lack of CD40 up-regulation (Supplementary Fig. 6b). Several 
other innate pathways were also not involved because MAIT cell activation was unaffected 
when using BMDCs from mice deficient for Nod1- and Nod2-18, 19, Nlrp3- and Asc-20-22, or 
Ips1-23-25 (Supplementary Fig. 6a and 6b). These results indicate that DC-activation through 
the main microbial recognition pathways is not sufficient for MAIT cell activation. 
Both human (Fig. 1a) and mouse iVα19 Tg (Fig. 2b) MAIT cells were activated by 
autologous E. coli-infected APCs. However, previous reports show these cells do not react to 
transduced cell-lines expressing high amounts of human or mouse MR1 at their cell surface26, 
27. This discrepancy strongly suggests that a ligand, presented by MR1, is provided during the 
APC-bacteria coculture and is necessary for MAIT activation. Therefore, we tested the 
capacity of cell lines to activate MAIT cells after bacterial coculture. WT3 mouse fibroblasts 
co-cultured with E. coli, which does not invade this cell type, could activate purified iVα19 
and iVα19-Vβ6 Tg T cells (Fig. 6a and Supplementary Fig. 7a, respectively). This activation 
was significantly increased when using cells over-expressing mMR1 (WT3-mMR1) and was 
completely blocked by anti-MR1 antibody, indicating that this response depends on MR1 
expression by the WT3 cells. We obtained similar results using human MAIT cells stimulated 
by HeLa cells expressing human MR1 (Supplementary Fig. 7c). To test for the presence of 
an exogenous ligand, we fixed WT3 and WT3-mMR1 cells with glutaraldehyde prior to 
bacterial co-culture so that no processing and/or upregulation of an endogenous ligand could 
occur. We observed a significant proportion of iVα19 and iVα19-Vβ6 Tg MAIT cells activated 
by WT3-mMR1 but not WT3 cells (Fig. 6b and Supplementary Fig. 7b).  The activation of 
iVα19 Tg cells by WT3-mMR1, even fixed, in the presence of bacteria, indicates that MAIT 
cells recognize an exogenous ligand presented by MR1. 
 
MAIT cells have an antibacterial function in vivo 
The reactivity of MAIT cells towards cells co-cultured with bacteria, the acquisition of a 
memory phenotype after birth in human and their absence in germ-free mice7 suggest that 
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colonization by the commensal flora induces expansion of these T cells in vivo. To test this 
hypothesis, we reconstituted germ-free animals with mono-microbial flora. Consistent with 
our previous findings7, iVα19-Jα33 mRNA levels in the mesenteric lymph nodes (MLN) of 
Tap-/-Ii-/-Mr1+ germ free and Tap-/-Ii-/-Mr1-/- mice were comparable (Fig. 7a). Feeding germ-
free Tap-/-Ii-/- animals with a single strain of bacteria, including either Enterobacter cloacae, 
Lactobacillus casei, Bacteroides thetaiotaomicron or Bifidobacterium animalis, increased 
iVα19-Jα33 mRNA levels in the MLN back to those found in conventional Tap-/-Ii-/-Mr1+ mice 
(Fig. 7a and data not shown), demonstrating that single microbial flora are sufficient to 
induce MAIT cell expansion. In contrast, feeding E. faecalis failed to generate a detectable 
MAIT population (Fig. 7a), further suggesting that this bacterium does not provide the ligand 
necessary for MAIT cell activation. 
We then examined whether MAIT cells display anti-bacterial properties in vivo. We 
followed MAIT cell activation and E. coli clearance after intraperitoneal injection. Both 
iVα19 and Vβ6 Tg Mr1-/- mice harbored elevated colony forming units (CFUs) in the spleen 3 
days after infection, as compared to their Mr1+ counterparts (Fig. 7b). iVα19 Tg mice 
exhibited better protection compared to Vβ6 Tg mice, correlating with higher MAIT 
numbers8. T cells in iVα19 Tg Mr1+ animals accumulated in the peritoneal cavity (Fig. 7c) 
and up-regulated CD25 surface expression (Fig. 7d). Moreover, in an Mr1+ background, T 
cells expressing the Vβ6 or Vβ8 segments displayed higher CD25 expression compared to 
cells expressing neither of these Vβ segments (Fig. 7d), further suggesting activation is MAIT 
cell-specific. Furthermore, consistent with our in vitro data (Supplementary Fig. 5), MR1-
deficient mice were not more sensitive to influenza viral infection than wild-type (WT) mice 
(data not shown). Taken together, these results indicate that MAIT cells are recruited and 
activated at the site of infection and have anti-bacterial properties. 
We next examined the role of MAIT cells in a mycobacterium infection model using 
Mycobacterium abscessus28. M. abscessus-infected BMDCs strongly stimulated mouse MAIT 
cells in a dose- and MR1-dependent manner (Fig. 8a), while Mr1+ and Mr1-/- BMDCs were 
activated similarly by the bacteria (data not shown). We injected intravenously 106 bacteria 
into non-transgenic, iVα19 or Vβ6 Tg mice, as well as Tap-/-Ii-/- and Cd3-/- mice on either 
MR1-sufficient or -deficient backgrounds. iVα19-Mr1-/- and Vβ6-Mr1-/- Tg mice harbored 
higher bacterial load in the spleen 15 days after infection than their Mr1+ littermates (Fig. 8b). 
No significant difference was observed between Mr1+ and Mr1-/- non-transgenic animals. Tap-
/-Ii-/- animals (that have impaired conventional T cell and increased MAIT cell numbers), 
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exhibited increased bacterial burdens compared to wild-type mice but even more so in the 
absence of MR1 suggesting that the increased proportion of MAIT cells found in these mice 
leads to some protection. Similarly, Cd3-/- animals had an impaired response to M. abscessus 
compared to WT, however no difference could be seen between Mr1+ and Mr1-/- mice in this 
genotype confirming that the protection observed is T cell mediated. Altogether, these data 
indicate an important role for MAIT-mediated immune responses against mycobacterium 
infections. 
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Discussion 
MAIT cells are highly conserved between species and very abundant in humans, but 
no function has yet been described. We now show that human and mouse MAIT cells respond 
to bacteria- or yeasts-infected APCs in an MR1-dependent manner. MAIT cells react to APCs 
cocultured with various bacteria including Enterobacteriacea, Staphylococci and 
Mycobacterium, but not Streptococci or E. faecalis. Activation is independent of the classical 
MHC class I and II pathways and from the main innate immune receptors. In mice, MAIT cell 
activation mediates antibacterial functions in two different infection models. Finally, MAIT 
cell frequencies are significantly decreased in the blood of bacterially-infected patients. This 
observation can be explained by the migration of these cells into infected tissues suggesting 
that, like in mice, human MAIT cells play a role in the antibacterial response. 
The acquisition of memory phenotype by human MAIT cells after birth suggested that 
the commensal flora induces MAIT cell maturation and expansion. In mice, MAIT cells are 
naïve and in small numbers8, which could result from a missing genetic element arising from 
the genetic bottleneck of laboratory mice or from the cleanliness of mouse facilities. We show 
that MAIT cells are absent in germ-free mice but can be recovered after colonization with 
bacteria, clearly indicating an interaction between MAIT cells and the commensal flora. 
Hence, the gut flora could drive the expansion of MAIT cells directly by MR1-dependent 
interactions or indirectly through the constitution of trophic niches. The fact that human and 
mouse MAIT cells are activated by ubiquitous bacteria does not exclude that, in vivo, the 
expansion of MAIT cells could be driven by one particular undefined microbe with special 
properties, as observed in the case of Bacteroides fragilis29 or segmented filamentous 
bacteria30, 31. 
The wide specificity of MAIT cells for phylogenetically distant microbial entities, and 
the observed cross-reactivity between human and mice, suggest that MAIT cells recognize a 
conserved antigen. Human MAIT cells did not react against cells over-expressing human 
MR126 suggesting that a ligand might have been missing in the MR1 groove. We now find 
that human MAIT cells can recognize MR1 expressed on APC or hMR1 over-expressing 
fibroblasts cocultured with bacteria. Similarly, Vβ6+ and Vβ8+ T cells from iVα19 single Tg 
mouse recognize mMR1 on infected mouse APC but not on uninfected MR1-transduced cell 
lines. Altogether, these results suggest that human and mouse MR1 present a ligand, which is 
either provided or induced by the bacteria. 
The characterization of the ligand presented by MR1 is the next main challenge in 
MAIT cell research. Previous reports have proposed that MAIT cells were activated by a 
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lipidic compound, α-Mannosyl-ceramide, presented by MR132. We could not reproduce this 
data using this compound in our experimental settings (data not shown). We also failed to see 
any effect of N-butyldeoxynojirimycin, a drug that inhibits glycolipid biosynthesis33 (data not 
shown) arguing against the possibility of a lipidic ligand loaded on MR1. Even though the 
human MAIT cell population is oligoclonal8, most of these cells are activated by various types 
of bacteria and yeasts, suggesting the absence of fine TCR specificity towards various 
unrelated microbes. One possible explanation would be that all these microbes induce the 
upregulation of an endogenous ligand, which might be also necessary for thymic selection. 
However, our observations that fixed cells expressing MR1 can activate MAIT cells, in the 
presence of bacteria, indicates the existence of an exogenous antigen. This ligand could be 
either of multiple composition, but the MR1-iTCR interaction would be non-discriminative, 
or an extremely conserved compound among microbes.  
The existence of a highly conserved microbial-derived product inducing 
immunological responses is reminiscent of the ligands of the innate immune system34, 35. It is 
therefore surprising that none of the tested cells deficient for major innate immune pathways 
(MyD88, Trif, Nod1 and/or Nod2, Nlrp3 or Asc, Ips1) impacts strongly on MAIT cell 
activation. Also, pure TLR ligands could not recapitulate the activation triggered by whole 
bacteria. Thus, cellular activation alone cannot trigger the APC to become competent to 
activate MAIT cells. These results contrast with NKT cell activation where TLR-9 and -4 
ligands induce the upregulation of an endogenous ligand loaded on CD1d36, 37.  
B cells have been implicated in MAIT cell expansion in the periphery7, 8. However, to 
date, there are no satisfactory results showing a direct activation of MAIT cells by B cells. 
Further experiments are necessary to formally address this question. Nonetheless, we show 
that MAIT cells can be activated by various types of cells (DCs, macrophages, epithelial and 
fibroblastic cells), suggesting that the pathway necessary for MR1 processing and loading are 
broadly expressed. TAP and the Ii chain, essential players in the MHC class I and class II 
pathways, are not required for MAIT cell ontogeny7, 9. In this study, we establish that they are 
also not necessary for MR1-dependent activation. Studies have reported that some exogenous 
antigen processing could occur in the absence of TAP, a process named vesicular 
processing38, 39. MR1 could utilize such a pathway to stimulate MAIT cells after bacterial 
triggering. Our results showing that fixed cells over-expressing MR1 can activate MAIT cells 
suggest that a bacterial product can be directly loaded on the MR1 molecule without 
processing. However, such circumstances are non-physiological because MR1 expression at 
the cell surface has not been detected in non-transduced settings26. Accordingly, MR1 loading 
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with the putative ligand could occur in a specific compartment of the endosomal pathway. 
The microbial trigger could induce the production and trafficking of MR1 through this 
compartment en route to the cell membrane similarly to what has been described for the MHC 
class Ib molecules H2-M340, 41.  
MAIT cells have a clear antibacterial function that could be attributed to the production 
of IFN-γ42. The concentrations are moderate compared to conventional memory T cells 
stimulated with CD3 and CD28 antibodies. However, the absence of conventional CD4 and 
CD8 T cell activation with infected APCs is striking. In mice, increased MAIT numbers 
correlates with increased protection against infection of E. coli. In the M. abscessus infection 
model, we observe no significant difference between Mr1+ and Mr1-/- non-transgenic mice 
that have low MAIT frequency, while we do in Vα19 and Vβ6 transgenic mice that have 
increased MAIT numbers, closer to what is observed in humans. We can speculate that MAIT 
cell function resides in the prompt response of these cells at the site of infection. MAIT cell 
ontogeny and their ability to respond to a wide variety of bacteria including commensals in 
the gut might suggest a dual role; in defense against infections, depicted in the present study, 
and possibly in mucosal homeostatic mechanisms. 
The results presented here show that MAIT cells respond to microbes and participate in 
anti-bacterial immune responses in both human and mouse. MAIT cells represent an 
evolutionarily conserved innate-like lymphocyte population that senses and participates to 
immune responses against microbes. MAIT cells represent the first T cell population that 
distinguishes between microbial and viral challenges. Considering the abundance of this cell 
type in humans, their wide microbial specificity and their protective capacity, MAIT cell 
manipulation could have significant impact on vaccine and therapeutic drug development 
against infectious diseases. 
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Figure legends 
Figure 1: Human MAIT cells respond to bacteria-infected monocytes in an MR1-
dependent manner and are decreased in the blood of bacterial infected patients. 
(a) Vα7.2+ sorted cells activation by E. coli infected APCs. Gray: non-infected. Black: 
infected. Representative of more than 5 experiments. 
(b) Activation of human MAIT cells by monocytes cocultured with increasing MOI: 0 
(gray), 0.1 (thin black), 1 (heavy gray) and 10 (heavy black). Representative of 3 experiments. 
(c) Blockade of sorted Vα7.2+ cell activation by 26.5 anti-MR1 antibody (red) or isotype 
control (black). Gray: non-infected. Representative of 3 experiments. 
(d) Production of IFN-γ by flow-sorted memory (CD45RO+) CD4 and CD8 
conventional and MAIT (Vα7.2+CD161+) T (CD3+) cells after 48 hour co-culture with 
autologous monocytes infected with E. coli at various MOI (0: white, 1: light gray, 10: gray 
and 100: dark gray) or monocytes alone (-). Anti-CD3/CD28 stimulated T cells (black) are 
shown as controls. Mean and SEM of 2 different donors. Representative of 3 experiments. 
(e) Blockade of IFN-γ production by FACS sorted MAIT cells as in (d) with or without 
blocking anti-MR1 antibody in control condition (0) and with E. coli infection (MOI of 10). 
Mean and SEM of 3 independent experiments (*p<0.01. paired t-test). 
 
Figure 2: Human MAIT are decreased in the blood of bacterially infected patients. 
(a) Proportion of MAIT (Vα7.2+CD161+CD3+TCRγδ- cells) and b) γδ T cells in the 
blood of healthy donors or patients with the indicated pathology. (*p<0.001, NS: non-
significant. Mann-Whitney test) 
(c) Human T cells were gated on CD3+Vα7.2+CD4- cells. CD161+ cells (defined 
previously as MAIT cells) correlated well with IL-18Rα+ cells. 
(d) M. tuberculosis infected lung H&E and immunostaining. Arrows indicate triple-
stained MAIT cells. 
(e) Representative plot of indicated tissues. Selected plot representative of the geometric 
median indicated above the gate and numbers below indicate range of percent cells in gate for 
each group for the indicated number of patients. 
 
Figure 3: T cells from mouse transgenic (Tg) for the specific MAIT TCR Vα and/or Vβ 
chains respond to E. coli infected APCs through MR1. 
(a) Activation of mouse iVα19-Vβ6 Tg MAIT cells by bacteria-infected Mr1+ or Mr1-/- 
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BMDCs. Gray: non-infected; Black: infected. Representative of more than 5 experiments. 
(b) Activation of iVα19 transgenic T cells according to Vβ6 or Vβ8 segment expression. 
Gray: non-infected; Black: infected. Representative of more than 5 experiments. 
(c) T cells as in a) co-stained for CD69 and CD25 after overnight co-culture with non- 
infected (0) or infected (10) Mr1+ or Mr1-/- BMDCs. Representative of more than 5 
experiments. 
(d) IL-2 production by MAIT cells after stimulation by infected Mr1+ (closed triangle) 
or Mr1-/- (open triangle) BMDCs. Representative of 2 experiments. Mean and SEM are 
plotted. (*p<0.05, ANOVA) 
(e) iVα19-Vβ6 bead-sorted MAIT cells were CFSE-stained and stimulated as in (a). 
Activation assayed by CD25 up-regulation and proliferation by CFSE dilution was assessed at 
day 2 and 5. Representative of 2 experiments. 
 
Figure 4: MAIT cell activation requires a highly conserved cognate interaction between 
MR1 and the TCR, as well as internalization of exogenous compounds but is independent of 
classical MHC class I and class II presentation pathways. 
(a) Mr1+ and Mr1-/- BMDC were fixed at the indicated time points after infection before 
MAIT cell (iVα19-Vβ6 Tg) overnight co-culture. Gray: non-infected. Black: infected. 
Representative of 2 experiments. 
(b) E. coli (E.c.) infected (black) or non-infected (white) BMDCs were treated with 
indicated drugs or left untreated before infection and stimulation of MAIT cells. 
Representative of 3 experiments. (*p<0.05, Mann-Whitney test) 
(c) BMDC from WT (upper panels) or Tap-/-Ii-/- mice (lower panels) in a Mr1+ (left) or 
Mr1-/- (right) background were infected (black) or left uninfected (gray) before overnight co-
culture with responding T cells. Representative of 2 experiments. 
(d) Human monocytes (hMono) or mouse Mr1+ (mMr1+) or Mr1-/- (mMr1-/-) 
macrophages were infected with E. coli at the indicated MOI. Sorted human MAIT cells were 
seeded on these three populations and activation assessed after overnight co-culture by CD69 
staining. Representative of 2 experiments. 
(e) Human monocytes were infected as indicated in (a) and hybridomas expressing 
mouse MAIT specific TCR used as responding cells. Activation was assessed by IL-2 
secretion. Representative of 2 experiments. 
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Figure 5: MAIT cells respond to phylogenetically diverse microbes. 
(a) Activation of iVα19-Vβ6 Tg T cells by BMDC cultured with live- (closed triangle) 
or paraformaldehyde (PFA)-treated- (closed circle) or heat-killed-(HK) (closed square) E. coli 
or non-infected control (open diamond). Representative of 2 experiments. 
(b) E. coli (closed triangle, Ec), P. aeroginosa (closed inverted triangle, Pa), K. 
pneumoniae (closed square, Kp), L. acidophilus (closed circle, La), S. aureus (open square, 
Sa), S. epidermidis (open circle, Se), Streptococcus group A (open triangle, SA), and E. 
faecalis (inverted open triangle, Ef) were tested for their ability to activate iVα19-Vβ6 Tg T 
cells. Non-infected controls (open diamond). Representative of 3 experiments. 
(c) BMDCs from wild type or MR1-deficient mice were infected with mixed 
suspensions of PFA-fixed bacteria at different ratios of E. coli : E. faecalis, while the total 
MOI remained constant at 1 or 10. Bacteria were fixed with PFA to avoid differential growth 
rates by the two different strains. iVα19-Vβ6 Tg T cell activation by this APCs was assessed 
by CD69 and CD25 up-regulation.  Representative of 3 experiments. 
(d) C. albicans (closed circle, Ca), C. glabrata (closed diamond, Cg), and S. cerevisiae 
(closed square, Sc) infected-BMDC were fixed 4 hours after infection and iVα19-Vβ6 Tg T 
cells added for overnight stimulation. Non-infected controls (open diamond). Representative 
of 3 experiments. 
 
Figure 6: Fibroblastic cells can induce MAIT cell activation through MR1, which can 
present an exogenous bacteria-derived ligand. 
(a) The mouse fibroblastic cell line WT3, and the stably-transfected cell line over-
expressing mouse MR1 (WT3-mMR1) were co-cultured with various MOI of E. coli to serve 
as APC to iVα19 Tg T cells. MAIT activation was assessed by CD69 and CD25 up-regulation 
in the presence or absence of blocking anti-MR1 antibody (αMR1). Pool of 4 independent 
experiments. Bars represent mean and SEM; *p<0.05, paired t-test. 
(b) WT3 and WT3-mMR1 cells were fixed by glutharaldehyde prior to co-culture with 
E. coli at the indicated MOI and extensively washed after 3 hours of stimulation. Then, iVα19 
Tg T cells were seeded on the cell layer and activation assessed by CD69 and CD25 up-
regulation. Pool of 4 independent experiments. Bars represent mean and SEM; *p<0.05, 
paired t-test.  
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Figure 7: MAIT cell bacteria-dependent expansion, activation at the site of infection 
and anti-bacterial function. 
(a) Mono-microbial flora infection allows reconstitution of MAIT cell numbers in 
germ-free mice. iVα19 mRNA levels in the MLN of Mr1+ or Mr1-/- mice in a Tap-/-Ii-/- 
background. Germ-free Mr1+Tap-/-Ii-/- mice were reconstituted with the indicated bacteria: E. 
cloacae (Ec), L. acidophilus, (La) and E. faecalis (Ef). Individual mice were analyzed in 
different batches and pooled data are presented. (*p<0.05; Student's t-test) n = 4 to 6 per 
group. 
(b) Lower bacterial counts in mice over-expressing MAIT cells after 107 CFU E. coli 
intra-peritoneal injection. CFU counts in the spleen of iVα19 or Vβ6 transgenic mice in an 
Mr1+ (closed triangle) or Mr1-/- (open triangle) background. Bars represent Median. Pooled 
data of 2 independent experiments. (*p<0.05; **p<0.01; Mann Whitney test). n = 8 to 16 per 
group. 
(c) MAIT cells accumulate at the site of infection. Total T cell, Vβ6+or Vβ8+, and Vβ6- 
and Vβ8- cell counts in the peritoneal lavage of infected or uninfected (Uninf.) Mr1+ and Mr1-
/- mice. Representative of 3 independent experiments (*p<0.01; Mann Whitney test). n = 3 to 
4 per group. 
(d) Proportion of activated (CD25+) cells in uninfected (Uninf.: diamond), Mr1+ (closed 
triangle) or Mr1-/- (open triangle) mice, according to Vβ expression: Vβ6+ or Vβ8+ cells and 
Vβ6-Vβ8- cells. Representative of 2 independent experiments (Bars represent mean; *p<0.01; 
Mann Whitney test) n = 2 to 12 per group. 
 
Figure 8: MAIT cells anti-mycobacterium activity. 
(a) BMDCs from Mr1+ or Mr1-/- mice were infected with M. abscessus at various MOI. 
MAIT cell activation was assessed by CD69 up-regulation after overnight culture. 
Representative histogram plots and dose response out of 5 experiments. 
(b) M. abscessus CFU counts in the spleen of wild type (WT), iVα19 or Vβ6 Tg and 
Tap-/-Ii-/- or Cd3-/- deficient mice in an Mr1+ (closed triangle) or Mr1-/- (open triangles) 
background, as well as B6 controls (closed square) 15 days after i.v. injection of 106 M. 
abscessus. Pooled data of 2 independent experiments. Bars represent Median. (*p<0.05 Mann 
Whitney test). 
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Methods 
Mice:  
Mice used in this study have been described previously8. Briefly, Vβ6 Tg mice were 
generated on the B6 background and iVα19 Tg mice and MR1 deficient mice are backcrossed 
onto B6 background for more than 10 generations. TAP-Ii double deficient animals are on a 
mixed B6/129 background. All iVα19 transgenic animals are on a Cα deficient B6 
background to avoid endogenous Vα expression. All experiments were conducted with 
littermates. 
In addition, MyD88-, Trif-, Nod1-, Nod2-, Nlrp3-, Asc-, Ips1- knockout bone-marrows 
were kindly provided by Michel Chignard, Lena Alexopoulou, Dana Philpott, Jurg Tschopp 
and Mathew Alberts, respectively and have been described elsewhere15, 20, 43-45. All mice were 
housed in our accredited SPF colony and genotyped by PCR or FACS staining, as 
appropriate. Live animal experiments were done in accordance with the guidelines of the 
French Veterinary Department. 
Germ-free mice were housed at the (TAAM, CNRS. Orléans, France) and were fed with 
single bacteria as indicated. Colonization was verified several times during the experiments. 
Two to 3 months after reconstitution, MLN were harvested and MAIT cell numbers were 
measured by real time RT-QPCR as described7. 
 
Cell preparation:  
Cell suspensions were prepared from spleen, peripheral or MLN by mechanical 
disruption on cell strainers. 
Cells were cultured in DMEM+Glutamax supplemented with 10% FCS, Penicillin and 
Streptomycin, non-essential amino-acids, HEPES and sodium pyruvate (all from Gibco). 
BMDC were prepared as previously described46. Briefly, bone marrow was obtained 
from legs of 6-12 weeks old mice and cultured for 7 days in the presence of 20% J558 
culture supernatant or 20ng/mL recombinant GM-CSF (Peprotech). Cells were fed at day 3 
and 5 with fresh media. 
For in vitro T cell activation, splenocytes were incubated with magnetic beads (anti-
CD11c and anti-CD19. anti-CD4 where added for cytokine secretion experiments) prior to 
magnetic separation using the MACS Pro system according to the manufacturer 
recommendation (Miltenyi). Purity and yield of the depletion or enrichment were checked 
by FACS analysis. 
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The cell lines WT3 and WT3-mMR1 (stably over-expressing the mouse MR1 molecule) 
have been described elsewhere27. 
 
Human samples 
Blood samples were obtained from healthy donors from the blood bank in accordance 
with institutional regulations. 
PBMCs were obtained using a standard Ficoll gradient according to the manufacturer 
protocol (GE healthcare). Monocytes were isolated by adherence on plastic culture plates. 
MAIT cells were isolated by MACS sort using the biotinylated anti-Vα7.2 antibody and anti-
biotin magnetic beads (Miltenyi) according to the manufacturer specifications. 
Patient blood samples were obtained as leftover after hematological analysis from 
patients treated for infectious diseases in department of immunology of la Pitié-Salpétrière 
Hospital. All patients with a known immunodeficiency or low CD4 counts were excluded 
from the analysis. Similarly, blood was obtained from patients followed for various solid 
tumors at Institut Curie and who had not received previous treatments (no chemo- nor radio-
therapy).  In our institution, all patients are informed that pathological specimens may be 
used for research purposes. 
 
Microbes, infection and activation 
All bacteria were kindly provided by the clinical microbiology laboratories of the Curie 
Institut and are ATCC reference strains. Bacteria were cultured overnight in Luria broth at 
37°C, washed in PBS and diluted according to needs. Except M. abscessus, strain CIP 
104536T-R, grown and used as previously described28. Where indicated, bacteria were fixed 
in 1% PFA for 5 min and then washed extensively before use. 
For in vitro infection, cells were washed and put in DMEM without supplement. 
Dilutions of bacteria in DMEM were added for 3 hours or other periods of time where 
indicated. At this point cells were washed two times in DMEM, 10% FCS, supplemented with 
penicillin and streptomycin. Purified T cells were added for an overnight co-culture or longer 
where indicated, then cells were harvested and stained for FACS analysis. 
For drug treatments, cells were cultured for 1h in medium supplemented with 
Cytochalasin D (5μg/mL), Dynasore (80μM), Lactacystin (5μM) or DMSO and Chloroquine 
(50μM) or left untreated, prior to infection. After 3 hours of infection cells were washed. 
Where indicated, APCs were fixed with 0.05% glutaraldehyde for 2 min and quenched with 
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glycine and thoroughly washed with complete medium before adding responder cells or 
bacteria. 
For in vivo infection, mice were injected i.p. or i.v. with 107 E. coli and 106 M. 
abscessus respectively, in PBS.  
 
Flow cytometry 
Flow cytometry was performed with directly conjugated antibodies (BD Pharmingen) 
according to standard techniques with analysis on a FACS Aria and LSRII flow cytometers 
(Becton Dickinson). DAPI and a 405 nm excitation were used to exclude dead cells.  The 
following antibodies, mostly from BD Pharmingen or eBiosciences, were used in mice: anti-
Vβ6-PE or FITC (RR4-7), anti-Vβ8-PE or FITC (F23.1) anti-CD44-PE or APC (IM-7), anti-
TCRβ-PC5 (H57-597), anti-CD8α-APC-Cy7 (Ly-2), anti-CD4-Alexa-700 (L3T4), anti CD69-
PE-Texas-Red or APC (H1.2F3), anti-CD25-PE-TexasRed (PC61), anti-CD11b-APC 
(MI/70), anti-CD40-PE (3/23), anti-CD11c-APC-Cy7 (HL3) and anti-CD86-PE (6L1). 
For human cell staining, the following were used: anti-CD4-APC-Cy7 (RP4-T4), anti-
CD3ε-Alexa 700 (UCHT1), anti-TCRγδ-PC5 (IMMU510), anti-CD8β-PE Texas Red 
(2ST8.5H7), anti-CD45RO-Fitc (UCHL1), anti-CD161-APC (DX12), anti-CD69-APC 
(CH/4) and anti-CD11b-FITC (B-Ly6). The antibody Vα7.2 (3C10) has been described 
elsewhere8. 
 For quantification of cytokines, CBA (BD biosciences) technology was used 
according to the manufacturer specifications. 
 
Statistical analysis: 
All quantitative data were analyzed on Prism software using paired, unpaired t-test, non-
parametric (U Mann-Whitney) or ANOVA where indicated. 
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